Susan Chi
Dana-Farber Cancer Institute · Dana Farber/ Boston Children's Cancer and Blood Disorders Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Susan Chi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:49 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07390539 · B7-H3.CD28Z.CART in CNS NeoplasmsRobbie Majzner · recruiting · Central Nervous System Neoplasms, Brain Tumor, Brain Tumor, Recurrent · principal investigator
- Early Ph1NCT06333899 · Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionNationwide Children's Hospital · recruiting · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma · study chair
- Ph1/Ph2NCT05407441 · Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def TumorsSusan Chi, MD · active not recruiting · Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant Tumors · principal investigator
- Early Ph1NCT04655404 · A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK FusionNationwide Children's Hospital · recruiting · High Grade Glioma, Diffuse Intrinsic Pontine Glioma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 14 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in ependymoma, ranked by citations from NIH iCite, fetched 2026-11-12 10:49 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.Pediatr Blood Cancer · 2014112 citationsRCR 3.6
- Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma.Neuro Oncol · 201974 citationsRCR 2.9
- Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience.J Neurooncol · 202068 citationsRCR 2.9